Celltrion is a biopharmaceutical company based in South Korea that develops and manufactures biologic medicines, chiefly biosimilars of antibody-based treatments used in immunology and oncology. It produces these medicines at its own facilities and supplies them to healthcare providers and partners in markets around the world. The company also carries out research and development work on new biologic products and works with international pharmaceutical partners to bring its medicines to patients.
On this site Celltrion Inc appears as a stock on the Korea Stock Exchange (Korea), code 068270, with prices in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #60 of 934 on the Korea Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Korea yet.
TrendStrong
80/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average2.5%
From 52-week high-21.8%
MomentumStrong
80/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return14.2%
6-month return0.0%
12-month, skipping last month5.6%
Stability (higher is calmer)Fair
70/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)41.1%
Worst drawdown, 1 year (smaller is calmer)-32.6%
LiquidityStrong
97/100
Trades actively.
See the numbers →
Avg daily value traded103,205.36M KRW
Zero-volume days0.0%
IncomeWeak
27/100
Dividend is small or irregular.
See the numbers →
Dividend yield0.4%
Years with dividends5
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Korea when fundamentals data for this market is added. All Korea stocks.
52-wk range 158,500.00 – 251,000.02Daily closes, split-adjusted
Signals
50-day average187,626.00
200-day average189,589.92
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)6,044.73
Technical summary
Daily
Strongly bullish
12 bullish · 3 neutral · 1 bearish
Weekly
Strongly bullish
11 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
188,310.0
Bullish
EMA 10
190,583.1
Bullish
SMA 20
184,370.0
Bullish
EMA 20
187,218.4
Bullish
SMA 50
187,626.0
Bullish
EMA 50
185,313.4
Bullish
SMA 100
181,812.3
Bullish
EMA 100
184,872.9
Bullish
SMA 200
189,589.9
Bullish
EMA 200
183,566.6
Bullish
Oscillators (daily)
RSI (14)
62.95
Neutral
MACD (12, 26)
3,124.0
Bullish
Momentum (12)
6.41
Bullish
Stochastic %K (14)
69.13
Neutral
Williams %R (14)
-30.87
Neutral
CCI (20)
120.9
Bearish
Pivot points (classic, last session)
S3
183,666.7
S2
187,433.3
S1
190,866.7
Pivot
194,633.3
R1
198,066.7
R2
201,833.3
R3
205,266.7
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
750.00 KRW
Yield on today's price
0.39%
Frequency
Annual
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
750.0000
750.0000
500.0000
390.0000
765.0000
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in KRW. Educational only, not financial advice.
